The global demand for Lung Cancer Screening Market is presumed to reach the market size of nearly USD 6.82 BN by 2030 from USD 3.3 BN in 2022 with a CAGR of 9.5% under the study period 2023 - 2030.
Lung cancer screening is a medical procedure aimed at detecting lung cancer at an early and more treatable stage, often before symptoms develop. It involves using specific imaging tests to identify suspicious abnormalities in the lungs, typically in individuals who are at a higher risk of developing lung cancer. The primary objective of this screening is to improve the chances of early diagnosis and, consequently, better treatment outcomes.
The lung cancer screening market is experiencing growth driven by several key factors. Firstly, the rising incidence of lung cancer worldwide underscores the importance of early detection, spurring demand for screening. The smoking and lung cancer linkage has prompted public health campaigns and awareness efforts, encouraging high-risk individuals to seek screening services. Technological advancements, particularly in low-dose computed tomography (LDCT), have made lung cancer screening more accurate and accessible. Clinical guidelines from healthcare organizations and agencies recommend screening for specific high-risk groups, driving the adoption of screening programs. Aging populations face an increased risk of lung cancer, further fueling the demand for early detection through screening. Sophisticated risk assessment tools assist healthcare providers in identifying high-risk individuals. Patient education and healthcare policy changes have also contributed to increased screening rates. Integration of artificial intelligence (AI) into screening processes enhances accuracy, while ongoing research and clinical trials refine screening protocols. Telehealth and remote monitoring platforms expand access to screening, and the establishment of specialized cancer care centers with screening programs improves accessibility.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of lung cancer screening. The growth and trends of lung cancer screening industry provide a holistic approach to this study.
This section of the lung cancer screening market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Cancer Type
By Diagnosis Type
By End-User
This section covers the regional outlook, which accentuates current and future demand for the Lung Cancer Screening market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Lung Cancer Screening market include Koninklijke Philips N.V. (Amsterdam, Netherlands), Siemens Healthineers AG (Munich, Germany), Canon Medical Systems Corporation (Tochigi, Japan), GE Healthcare (Chicago, U.S.), FUJIFILM Holdings Corporation (Tokyo, Japan), Medtronic (Dublin, Ireland), Nuance Communications, Inc. (Burlington, U.S.), Eon (Denver, U.S.), PenRad Technologies, Inc. (Minnesota, U.S.), Volpara Solutions Limited. (Wellington, New Zealand), Other. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . LUNG CANCER SCREENING – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Cancer Type
3.7.2 Market Attractiveness Analysis By Diagnosis Type
3.7.3 Market Attractiveness Analysis By End-user
3.7.4 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL LUNG CANCER SCREENING MARKET ANALYSIS BY CANCER TYPE
5.1 Overview by Cancer Type
5.2 Historical and Forecast Data
5.3 Analysis by Cancer Type
5.4 Non-small Cell Lung Cancer (NSCLC) Historic and Forecast Sales by Regions
5.5 Small Cell Lung Cancer Historic and Forecast Sales by Regions
6 . GLOBAL LUNG CANCER SCREENING MARKET ANALYSIS BY DIAGNOSIS TYPE
6.1 Overview by Diagnosis Type
6.2 Historical and Forecast Data
6.3 Analysis by Diagnosis Type
6.4 Low Dose Spiral CT Scan Historic and Forecast Sales by Regions
6.5 Chest X-ray Historic and Forecast Sales by Regions
7 . GLOBAL LUNG CANCER SCREE ...